Gilead Sciences joins Alexion, Astrazeneca, ATS Scientific Products, Glaxosmithkline, Lilly, Roquette, and Sanofi on the CPPR Industrial Advisory Board.  We look forward to Gilead’s participation in our quest to advance pharmaceutical processing. The funds that Gilead has

committed to CPPR research are pooled with those of the other member companies.  The funds support rigorous academic research into industrially relevant pharmaceutical processing research at the CPPR academic sites, with mentorship from representatives from CPPR companies.

---